De novo HNF1A mutation of young maturity-onset diabetes 3 of a young girl-Case report

被引:1
作者
Peng, Haoran [1 ]
Li, Jianbo [2 ]
Wang, Zhang [3 ]
机构
[1] Chengdu Med Coll, Chengdu 610083, Peoples R China
[2] Southwest Med Univ, Luzhou 646000, Peoples R China
[3] Gen Hosp Western Theater Command, Dept Geriatr, Chengdu 610083, Peoples R China
关键词
MODY3 child Sulfonylurea Compounds; SOUTH INDIAN PATIENTS; RECEPTOR AGONIST; HYPOGLYCEMIA; DIAGNOSIS; MODY3; RISK; GENE;
D O I
10.1186/s12902-023-01293-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Young maturity-onset diabetes of the young type3(MODY3) as a special type of diabetes, the probability of diagnosis is low. This article reports on a case and reviews the relevant knowledge of the disease. We report an 11-year-and-11-month-old girl whose grandmother died from diabetic complications while the rest of the families were non-diabetes. The proband was initially treated with insulin and metformin but the threatment proved inefficient. After an exome-targeted capture sequencing test, she was diagnosed with mature-onset diabetes of young type 3 (MODY3), and sulfonylureas make sense. The key to mody treatment is a correct and timely diagnosis, which contributes to helping patients overcome the problems of MODY3, especially for blood sugar control.
引用
收藏
页数:5
相关论文
共 29 条
  • [1] Structure-function studies of HNF1A (MODY3) gene mutations in South Indian patients with monogenic diabetes
    Balamurugan, K.
    Bjorkhaug, L.
    Mahajan, S.
    Kanthimathi, S.
    Njolstad, P. R.
    Srinivasan, N.
    Mohan, V.
    Radha, V.
    [J]. CLINICAL GENETICS, 2016, 90 (06) : 486 - 495
  • [2] Exploring the role of miRNAs in the diagnosis of MODY3
    Baltaci, Oguzhan Fatih
    Colakoglu, Seyma
    Gullu Amuran, Gokce
    Aydin, Neslihan
    Sargin, Mehmet
    Karabay, Arzu
    Yilmaz, Temel
    Berber, Ergul
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (03) : 620 - +
  • [3] Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)
    Christensen, Alexander S.
    Haedersdal, Sofie
    Stoy, Julie
    Storgaard, Heidi
    Kampmann, Ulla
    Forman, Julie L.
    Seghieri, Marta
    Holst, Jens J.
    Hansen, Torben
    Knop, Filip K.
    Vilsboll, Tina
    [J]. DIABETES CARE, 2020, 43 (09) : 2025 - 2033
  • [4] Mutations in the Genes Encoding the Transcription Factors Hepatocyte Nuclear Factor 1 Alpha and 4 Alpha in Maturity-Onset Diabetes of the Young and Hyperinsulinemic Hypoglycemia
    Colclough, Kevin
    Bellanne-Chantelot, Christine
    Saint-Martin, Cecile
    Flanagan, Sarah E.
    Ellard, Sian
    [J]. HUMAN MUTATION, 2013, 34 (05) : 669 - 685
  • [5] MODY-3: NOVEL HNF1A MUTATION AND THE UTILITY OF GLUCAGON-LIKE PEPTIDE (GLP)-1 RECEPTOR AGONIST THERAPY
    Docena, Maricor K.
    Faiman, Charles
    Stanley, Christine M.
    Pantalone, Kevin M.
    [J]. ENDOCRINE PRACTICE, 2014, 20 (02) : 107 - 111
  • [6] HNF1A mutation presenting with fetal macrosomia and hypoglycemia in childhood prior to onset of overt diabetes
    Dusatkova, Petra
    Pruhova, Stepanka
    Sumnik, Zdenek
    Kolouskova, Stanislava
    Obermannova, Barbora
    Cinek, Ondrej
    Lebl, Jan
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (3-4) : 187 - 189
  • [7] Using Clinical Indices to Distinguish MODY2 (GCK Mutation) and MODY3 (HNF1A Mutation) from Type 1 Diabetes in a Young Chinese Population
    Fu, Junling
    Wang, Tong
    Liu, Jieying
    Wang, Xiaojing
    Zhang, Qian
    Li, Ming
    Xiao, Xinhua
    [J]. DIABETES THERAPY, 2019, 10 (04) : 1381 - 1390
  • [8] Spectrum of HNF1A Somatic Mutations in Hepatocellular Adenoma Differs From That in Patients With MODY3 and Suggests Genotoxic Damage
    Jeannot, Emmanuelle
    Mellottee, Lucille
    Bioulac-Sage, Paulette
    Balabaud, Charles
    Scoazec, Jean-Yves
    Van Nhieu, Jeanne Tran
    Bacq, Yannick
    Michalak, Sophie
    Buob, David
    Laurent-Puig, Pierre
    Rusyn, Ivan
    Zucman-Rossi, Jessica
    [J]. DIABETES, 2010, 59 (07) : 1836 - 1844
  • [9] Dipeptidyl Peptidase-IV Inhibitors Are Efficient Adjunct Therapy in HNF1A Maturity-Onset Diabetes of the Young Patients-Report of Two Cases
    Katra, Barbara
    Klupa, Tomasz
    Skupien, Jan
    Szopa, Magdalena
    Nowak, Natalia
    Borowiec, Maciej
    Kozek, Elzbieta
    Malecki, Maciej T.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (04) : 313 - 316
  • [10] Prevalence of monogenic diabetes in young adults: a community-based, cross-sectional study in Oxfordshire, UK
    Kropff, J.
    Selwood, M. P.
    McCarthy, M. I.
    Farmer, A. J.
    Owen, K. R.
    [J]. DIABETOLOGIA, 2011, 54 (05) : 1261 - 1263